| 9.35 -0.54 (-5.46%) | 12-31 19:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 13.16 |
1-year : | 13.28 |
| Resists | First : | 11.27 |
Second : | 11.36 |
| Pivot price | 11.24 |
|||
| Supports | First : | 11.1 |
Second : | 9.24 |
| MAs | MA(5) : | 11.29 |
MA(20) : | 11.22 |
| MA(100) : | 11.07  |
MA(250) : | 10.84 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 70.5 |
D(3) : | 90.1 |
| RSI | RSI(14): 39.4 |
|||
| 52-week | High : | 11.5 | Low : | 10.32 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ MACA ] has closed above bottom band by 12.0%. Bollinger Bands are 39.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 11.4 - 11.45 | 11.45 - 11.5 |
| Low: | 10.98 - 11.06 | 11.06 - 11.12 |
| Close: | 11.03 - 11.15 | 11.15 - 11.24 |
Montes Archimedes Acquisition Corp. focuses to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in Menlo Park, California.
Wed, 12 Jan 2022
Pardes Bio Allocating IPO Funds to Trial COVID-19 Drug, Ramp Up Staff - BioSpace
Fri, 01 Oct 2021
Roivant closes SPAC deal with Montes Archimedes - The Pharma Letter
Fri, 17 Sep 2021
High Redemption SPACs are on a Wild Reddit Meme Ride - TheStreet
Fri, 03 Sep 2021
De-SPACs are Falling as PIPE Shares Open Up for Sale - TheStreet
Fri, 20 Aug 2021
14 SPACs That Palantir Technologies Has Invested In Or Partnered - Palantir Technologies (NYSE:PLTR) - Benzinga
Wed, 09 Jun 2021
Roivant's Datavant, Ciox Health To Merge In $7B Deal - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Shell Companies
|
|
| Shares Out | 4 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 9.1 (%) |
| Held by Institutions | 11.3 (%) |
| Shares Short | 5 (K) |
| Shares Short P.Month | 5 (K) |
| EPS | 0.5 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.75 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -1.2 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 110 (M) |
| PE Ratio | 21.84 |
| PEG Ratio | 0 |
| Price to Book value | -15.06 |
| Price to Sales | 0 |
| Price to Cash Flow | 140.71 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|